161 related articles for article (PubMed ID: 26970415)
61. Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.
Norcia LF; Watanabe EM; Hamamoto Filho PT; Hasimoto CN; Pelafsky L; de Oliveira WK; Sassaki LY
Hepat Med; 2022; 14():135-161. PubMed ID: 36200122
[TBL] [Abstract][Full Text] [Related]
62. Polycystic liver disease: An uncommon genetic condition.
Limaiem F; Hajri M
Clin Case Rep; 2024 May; 12(5):e8892. PubMed ID: 38711839
[TBL] [Abstract][Full Text] [Related]
63. Drug holiday in patients with polycystic liver disease treated with somatostatin analogues.
van Aerts RMM; Kolkman M; Kievit W; Gevers TJG; Nevens F; Drenth JPH
Therap Adv Gastroenterol; 2018; 11():1756284818804784. PubMed ID: 30302127
[TBL] [Abstract][Full Text] [Related]
64. Isolated polycystic liver disease and aneurism: a case report.
Fassiadis N; Lampaki S; Zarogoulidis P; Tsavlis D; Tsiouda T; Kougioumtzi I; Machairiotis N; Pavlidis P; Charalampidis C; Tsakiridis K
Ann Transl Med; 2016 May; 4(9):167. PubMed ID: 27275480
[TBL] [Abstract][Full Text] [Related]
65. A psychiatric study of cases attending dental o.p.d of a teaching general hospital.
Shukla GD; Srivastava RP
Indian J Psychiatry; 1983 Jul; 25(3):198-202. PubMed ID: 21847286
[TBL] [Abstract][Full Text] [Related]
66. Analytic expressions for (s=1,2) and a method of computation for in rotating Morse oscillators.
Nagaoka M; Yamabe T
Phys Rev A Gen Phys; 1988 Nov; 38(10):5408-5411. PubMed ID: 9900265
[No Abstract] [Full Text] [Related]
67. Gigot-Suard on Herpetism.
Br Foreign Med Chir Rev; 1871 Oct; 48(96):335-337. PubMed ID: 30162810
[No Abstract] [Full Text] [Related]
68. US reports increase in liver cancer.
Gottlieb S
BMJ; 1999 Mar; 318(7186):755A. PubMed ID: 10082688
[No Abstract] [Full Text] [Related]
69. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease.
Chebib FT; Harmon A; Irazabal Mira MV; Jung YS; Edwards ME; Hogan MC; Kamath PS; Torres VE; Nagorney DM
J Am Coll Surg; 2016 Jul; 223(1):118-126.e1. PubMed ID: 27016902
[TBL] [Abstract][Full Text] [Related]
70. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.
Cabiddu G; Castellino S; Gernone G; Santoro D; Moroni G; Giannattasio M; Gregorini G; Giacchino F; Attini R; Loi V; Limardo M; Gammaro L; Todros T; Piccoli GB
J Nephrol; 2016 Jun; 29(3):277-303. PubMed ID: 26988973
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-β1 in Autosomal Dominant Polycystic Kidney Disease Patients.
Kocer D; Karakukcu C; Ozturk F; Eroglu E; Kocyigit I
Ther Apher Dial; 2016 Oct; 20(5):517-522. PubMed ID: 26991810
[TBL] [Abstract][Full Text] [Related]
72. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
[TBL] [Abstract][Full Text] [Related]
73. Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.
Chebib FT; Prieto M; Jung Y; Irazabal MV; Kremers WK; Dean PG; Rea DJ; Cosio FG; Torres VE; El-Zoghby ZM
Transplant Direct; 2015 Nov; 1(10):e43. PubMed ID: 26981586
[TBL] [Abstract][Full Text] [Related]
74. Clinical management of polycystic liver disease.
van Aerts RMM; van de Laarschot LFM; Banales JM; Drenth JPH
J Hepatol; 2018 Apr; 68(4):827-837. PubMed ID: 29175241
[TBL] [Abstract][Full Text] [Related]
75. The Importance of Recognizing Pain in Patients With Autosomal Dominant Polycystic Kidney Disease.
Geertsema P; Stellema R; Casteleijn NF
Kidney Med; 2024 May; 6(5):100821. PubMed ID: 38665994
[No Abstract] [Full Text] [Related]
76. Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement.
Righini M; Mancini R; Busutti M; Buscaroli A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473800
[TBL] [Abstract][Full Text] [Related]
77. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.
Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F
United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135
[TBL] [Abstract][Full Text] [Related]
78. Patient reported outcome measure thresholds: The next step in the management of polycystic liver disease.
Duijzer R; Gevers TJG
United European Gastroenterol J; 2023 Jun; 11(5):403-404. PubMed ID: 37128131
[No Abstract] [Full Text] [Related]
79. Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
Oberdhan D; Cole JC; Atkinson MJ; Krasa HB; Davison SN; Perrone RD
Clin J Am Soc Nephrol; 2023 Feb; 18(2):213-222. PubMed ID: 36754008
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
